A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

about

A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome.

Item

http://www.wikidata.org/entity/Q47149930

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@en

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@nl

type

Item

label

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@en

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@nl

prefLabel

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@en

A Retrospective Multicentric S ...... an 50: Management and Outcome.

@nl

P1476

A Retrospective Multicentric S ...... han 50: Management and Outcome

@en

P2093

Antoine Italiano

http://www.w3.org/2001/XMLSchema#string

Audrey Lardy-Cleaud

http://www.w3.org/2001/XMLSchema#string

Christine Chevreau

http://www.w3.org/2001/XMLSchema#string

Dominique Levy

http://www.w3.org/2001/XMLSchema#string

Dominique Ranchere

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Bompas

http://www.w3.org/2001/XMLSchema#string

Francois Bertucci

http://www.w3.org/2001/XMLSchema#string

Loic Chaigneau

http://www.w3.org/2001/XMLSchema#string

Pierre Meeus

http://www.w3.org/2001/XMLSchema#string

Sarah Dumont

http://www.w3.org/2001/XMLSchema#string

P2860

Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?

Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes

Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma

Survival after recurrence of Ewing's sarcoma family of tumors.

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.

Age as an independent prognostic factor for survival of localised synovial sarcoma patients

P2888

s41598-017-17733-z

P304

17917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-17733-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Alexandre Cassier

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29263409

http://www.w3.org/2001/XMLSchema#string

P932

5738347

http://www.w3.org/2001/XMLSchema#string